SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-020114
Filing Date
2024-03-05
Accepted
2024-03-05 16:02:41
Documents
100
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2023_jaspertherap.htm   iXBRL 10-K 1679168
2 DESCRIPTION OF SECURITIES OF JASPER THERAPEUTICS, INC f10k2023ex4-3_jasper.htm EX-4.3 53615
3 OFFER LETTER, DATED JUNE 7, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. AND E f10k2023ex10-35_jasper.htm EX-10.35 19035
4 OFFER LETTER, DATED SEPTEMBER 19, 2023, BY AND BETWEEN JASPER THERAPEUTICS, INC. f10k2023ex10-36_jasper.htm EX-10.36 19840
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2023ex23-1_jasper.htm EX-23.1 1913
6 CERTIFICATION f10k2023ex31-1_jasper.htm EX-31.1 10090
7 CERTIFICATION f10k2023ex31-2_jasper.htm EX-31.2 9995
8 CERTIFICATION f10k2023ex32-1_jasper.htm EX-32.1 6701
9 JASPER THERAPEUTICS, INC. CLAWBACK POLICY f10k2023ex97_jasper.htm EX-97 43281
15 GRAPHIC image_001.jpg GRAPHIC 20796
16 GRAPHIC image_002.jpg GRAPHIC 28623
17 GRAPHIC image_003.jpg GRAPHIC 30266
18 GRAPHIC image_004.jpg GRAPHIC 14795
19 GRAPHIC image_005.jpg GRAPHIC 15663
20 GRAPHIC image_006.jpg GRAPHIC 621968
21 GRAPHIC ex10-35_001.jpg GRAPHIC 20487
22 GRAPHIC ex10-36_001.jpg GRAPHIC 20475
  Complete submission text file 0001213900-24-020114.txt   8864224

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE jspr-20231231.xsd EX-101.SCH 68810
11 XBRL CALCULATION FILE jspr-20231231_cal.xml EX-101.CAL 40702
12 XBRL DEFINITION FILE jspr-20231231_def.xml EX-101.DEF 312332
13 XBRL LABEL FILE jspr-20231231_lab.xml EX-101.LAB 564653
14 XBRL PRESENTATION FILE jspr-20231231_pre.xml EX-101.PRE 313465
102 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023_jaspertherap_htm.xml XML 664102
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39138 | Film No.: 24720182
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)